Ryan D. Taylor

Ryan D. Taylor sells 19.7K PLTR shares for $2.7M at avg $136.04; holds 199.8K post-transaction

Ryan D. Taylor executed 5 separate sales totaling 19,662 shares for $2,674,859.35 on 2026-05-20, reducing his PLTR position by -9.0% versus pre-transaction holdings of 219,421 shares. His cross-ticker track record shows an avg 90d return of -11.7% after prior sells with a 90d well-timed rate of 75.00%, but at PLTR specifically, 0 of 5 prior sells were well-timed at the 90-day mark—all 5 prior same-ticker sales showed positive 90-day returns (+1.2% to +4.1%), meaning the stock rose after those sales. The current price of $136.88 is -34.0% from the 52-week high of $207.52 and down -10.3% over the 30-day window, yet PLTR's fundamentals remain strong with annual revenue growth of +56.2% and net income of $870,527,000.00 on quarterly revenue of $1,632,583,000.00.

Palantir insider Taylor Ryan D. sold 20.0K shares for $2.7M blended at $133.72 on 2026-02-20; stock down 24.0% in 30 days since trade.

Taylor Ryan D. executed 5 separate sales totaling 19,988 shares for $2,672,765.28 at prices ranging from $132.03 to $135.73, reducing holdings by 8.3% to 219,421 shares. The trade occurred as PLTR shares have declined 24.0% over the trailing 30 days and sit 37.8% below the 52-week high of $207.18, currently at $128.84. Across his cross-ticker track record, this insider has demonstrated a 100.00% well-timed rate on 20 prior sells (90-day average return -17.1%), and at PLTR specifically, 4 of 4 prior measurable sales were well-timed by the 90-day metric. The magnitude of this divestiture—$2.7M from a 219.4K-share base—combined with the established pattern of well-timed exits at this ticker warrants attention to near-term price momentum and any underlying business signals.

Taylor Ryan D. sold 12,000 shares of PLTR at $181.35 (2026-01-02); stock now $179.71, down -13.3% from 52-week high.

Taylor Ryan D. executed a sale of 12,000 shares at $181.35, reducing holdings by 4.8% to 239.4K shares. The transaction occurred near the equity's 52-week peak; the stock has since declined -13.3% from its high and trades -1.1% over 30 days. Across five prior trades at PLTR, all executed on 2025-11-24, the insider's 30-day returns ranged from +17.9% to +23.1%, suggesting a pattern of selling before near-term weakness. Current valuation remains stretched (P/E 390.67) relative to fundamental growth (28.8% annual revenue expansion), leaving limited margin for error; the insider's recent sale activity at this ticker merits monitoring to assess whether further liquidation may signal reassessment of near-term positioning.

Taylor Ryan D. sold 56,061 shares at blended avg $162.63 for $9.1M over 3 days, reducing stake to 251.4K shares

Taylor Ryan D. executed 30 separate sales totaling 56,061 shares for $9,117,228.49 across November 20–24, 2025, representing an 18.2% reduction in his PLTR holdings (from 307.5K to 251.4K shares). The multi-tranche execution at prices ranging from $153.43 to $173.41 suggests a systematic liquidation rather than a single-event transaction. His prior 5 PLTR sales all posted positive 90-day returns (ranging from 5.2% to 7.1%), indicating those prior exits were poorly timed; his cross-ticker track record shows 0 of 20 prior sells were well-timed at the 90-day mark (well-timed rate 0.00%), underscoring a consistent pattern of selling ahead of rallies rather than before declines. The current stock price of $162.25 sits only 0.2% below the blended average sale price, and the stock has declined 12.1% in the 30 days preceding this filing—a rare departure from the insider's typical post-sale price trajectory—warranting examination of whether macro, valuation, or company-specific factors drove this larger-scale exit.

Palantir insider Taylor Ryan D. sold 36,048 shares (36.0K) at $158.35 on 2025-09-05 for $5,708,056.61; post-transaction holding 307,470 shares.

Taylor Ryan D. executed an open-market sale of 36,048 shares at $158.35 on 2025-09-05, reducing holdings by 10.5% to 307,470 shares. The sale occurred during a period of volatility for PLTR; the stock has declined 13.2% over the past 30 days and 13.2% from its 52-week high of $186.97, though it remains up 19.0% over 90 days. This is the insider's sixth sell transaction at PLTR within the past two weeks (four sales on 2025-08-21 and one on 2025-08-20), indicating a sustained pattern of liquidation. While the insider's cross-ticker track record shows 20 prior sales with an average 30-day return of 5.0%, the PLTR-specific trading history has no yet-measurable outcomes, and the timing pattern shows 0 of 0 prior sells were well-timed at the 90-day mark. PLTR's fundamentals remain solid with $1.0B quarterly revenue, $326.7M net income, and 28.8% annual revenue growth, though the P/E of 507.38 reflects an elevated valuation.

Taylor Ryan D. sold 20,237 shares of PLTR over two days (Aug 20-21) for $3,103,617.33 at blended average $153.36

Taylor Ryan D. executed 18 separate sales totaling 20,237 shares for $3,103,617.33 over August 20–21, reducing holdings by 5.6% from 363,755 to 343,518 shares. The sales occurred at prices ranging from $143.12 to $156.15, well below the current price of $158.74; the blended average price of $153.36 sits 3.5% below current levels. At PLTR specifically, his prior two measurable sells (May 2025) returned +8.8% and +8.2% over 30 days, both positive outcomes that suggest the stock subsequently rose post-sale. His cross-ticker track record shows an average 90-day return of +38.4% following prior sells, indicating his prior sales were generally poorly-timed relative to subsequent price appreciation, though notably his same-ticker timing pattern at PLTR has not generated well-timed sells (0 of 2 prior 90-day outcomes were negative). The current sale occurred while the stock is up 28.7% over 90 days and 2.7% over 30 days, leaving limited absolute context about whether this sale precedes a pullback or continuation.

Taylor Ryan D. sold 30,000 PLTR shares at $175.00 on 2025-08-05; stock now at $182.20, up 30.4% in 30 days.

Taylor Ryan D. liquidated 30,000 shares (7.6% of pre-transaction holdings of 393.8K shares) at $175.00 on 2025-08-05, when PLTR has since rallied to $182.20 and is currently at 52-week high of $182.20. The timing of this sale relative to the subsequent 30-day +30.4% move is noteworthy. Across his cross-ticker track record, prior sells have returned +22.6% on average over 30 days, suggesting this insider's prior exit decisions were followed by continued upside; similarly, his five prior PLTR sales (most recent on 2025-07-15) show positive 30-day returns (ranging 8.2% to 17.0%) where measured, indicating his past sells at this ticker preceded further appreciation. The 0.00% 90-day well-timed rate in the track record reflects that his sells have consistently been followed by stock gains rather than declines, a pattern this transaction is replicating in early performance.

PLTR insider Taylor Ryan D. sold 33,335 shares at $150.00 on 2025-07-15 for $5,000,250.00, reducing holdings 8.4%.

Taylor Ryan D. sold 33,335 shares of Palantir at $150.00 on 2025-07-15, reducing his holdings from 397,090 to 363,755 shares. At current price of $153.99, this sale occurred 0.0% below the 52-week high. His cross-ticker track record shows 20 prior sells with a 90-day well-timed rate of 0.00%, indicating a pattern of selling ahead of stock appreciation rather than ahead of declines. At PLTR specifically, five prior trades show all recent sells followed by positive 30-day returns (+8.2% to +11.6%), with no measurable 90-day outcomes yet available to establish ticker-specific timing patterns. The sale is noteworthy given PLTR's strong 90-day momentum (+64.2%) and elevated valuation (P/E 641.62) relative to fundamental metrics (net income $214.0M on revenue $883.9M).

Taylor Ryan D. sold 33,335 PLTR shares at $135.31 on 2025-07-01 for $4,510,452.18; holdings reduce to 363,755 shares.

Taylor Ryan D. sold 33,335 shares at $135.31, reducing his holdings by 8.4% from 397,090 to 363,755 shares and realizing approximately $4.5M in proceeds. The sale occurred near the 52-week high—only 6.9% below the $144.25 peak—in a period where PLTR has surged 81.5% over the past 90 days. His cross-ticker track record shows a 0.00% well-timed rate on 20 prior sells with a positive average 90-day return of 51.3%, indicating prior sales have generally preceded further stock gains rather than declines. Same-ticker history at PLTR spans only recent May 2025 sales with positive short-term returns but no 90-day outcome data yet available for measurement. The company's fundamentals show strong recent performance—$883.9M quarterly revenue with 28.8% annual growth and $214.0M net income—though a P/E of 559.83 reflects a richly valued valuation.

Palantir insider Taylor Ryan D. sold 39,416 shares ($5.0M) across 7 transactions May 20–21 at blended avg $126.35; retains 363,755 shares. Current price $122.29, down 6.1% from 52-week high.

Taylor Ryan D. executed 7 separate sales totaling 39,416 shares for $4,980,241.39 at prices ranging from $125.26 to $127.71, representing a 9.8% reduction in holdings. The sales occurred over two trading days (May 20–21, 2025) at an average price of $126.35, while PLTR currently trades at $122.29—below the transaction prices by approximately 3.2%. The insider's cross-ticker track record spans 20 prior sells with an average 90-day return of +71.0% and a 0.00% well-timed rate (indicating that after prior sells, the stock typically rose, not fell). At PLTR specifically, five prior sells on 2025-03-31 all showed positive 30-day returns (+40.6% to +49.1%), with no 90-day outcomes yet measurable. The stock has posted strong recent momentum (+30.1% in 30 days, +20.7% in 90 days) and maintains a substantial market cap of $288.6B with recent quarterly revenue of $883.9M and net income of $214.0M, though the P/E of 509.54 reflects elevated valuation. The absence of disclosed plan documentation (10b5-1 or other) in the FACTS leaves the transaction's scheduled vs. discretionary nature unclear, and the magnitude and timing pattern relative to the insider's recent activity at this ticker merit closer review.